Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia

Urology

Volumn 49, Issue 1, 1997, Pages 50-54

  Batislam, Ertan ^a,b   Arik, A Ihsan ^a   Karakoc, Ali ^a   Uygur, M Cemil ^a   Germiyanoǧlu, R Cankon ^a   Erol, Demokan ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; INDWELLING CATHETER; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TRANSURETHRAL RESECTION;

CATHETERS, INDWELLING; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; URETHRA; URINARY CATHETERIZATION;

EID: 0031029984     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00386-X     Document Type: Article

References (21)

1. Papsidero LD, Kuriyama M, Wang MC, Horoszewicz JS, Leong SS, Valenzuela LA, Murphy GP, and Chu TM: Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 66: 37-42, 1981.
2. Nadji M, Tabei SZ, Castro A, Chu TM, Murphy GP, Wang MC, and Morales AR: Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer 48: 1229-1232, 1981.
3. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, and Vessella RL: Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138: 1181-1184, 1987.
4. Seamonds B, Yang N, Anderson K, Whitaker B, Show LM, and Bollinger JR: Evaluation of prostate specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology 28: 472-479, 1986.
5. Morote Robles J, Rubal Morell A, Palou Redorta J, de Torres Mateos JA, and Soler Rosello A: Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study. Eur Urol 14: 360-366, 1988.
6. Armitage TG, Cooper EH, Newling DW, Robinson MR, and Appleyard I: The value of the measurement of serum prostatic specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Br J Urol 62: 584-589, 1988.
7. Aus G, and Skutde G: Effect of ultrasound guided core biopsy of prostate on serum concentrations of prostate specific antigen and acid phosphatase activity. Scand J Urol Nephrol 26: 21-23, 1992.
8. Yuan JJJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, and Catalona WJ: Effects of rectal examination, prostatic massage, ultrasonography, and needle biopsy on serum prostate specific antigen levels. J Urol 148: 810-814, 1992.
9. Chybowski FM, Bergstralh EJ, and Oesterling JE: The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol 148: 83-86, 1992.
10. Oesterling JE, Rice DC, Glevski WJ, and Bergstralh EJ: Effect of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate specific antigen concentration. Urology 42: 276-282, 1993.
11. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Brulek DJ, Rock RC, Brendler CB, and Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766-772, 1988.
12. Walz PH, Schoppmann TH, Büscher C, Ennen J, and Schriewer H: Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen. Eur Urol 22: 20-26, 1992.
13. Ferro MA, Barnes I, Roberts JBM, and Smith BTB: Tumour markers in prostatic carcinoma. A comparison of prostate specific antigen with acid phosphatase. Br J Urol 60: 69-73, 1987.
14. Hudson MA, Bahnson RR, and Catalona WJ: Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142: 1011-1017, 1989.
15. Oesterling JE: In my view. Prospectives 4: 4-6, 1995.
16. Bazinet M, Péloquin F, Meshref AW, Nachabe M, Trudel C, Bégin LR, Arónson S, and Elhilali MM: Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 43: 44-52, 1994.
17. Rommel RF, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, and Stahl CA: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 151: 88-93, 1994.
18. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
19. Lindstedt G, Jacobsson A, Lundberg PA, Hedelin H, Pettersson S, and Unsgaard B: Determination of prostate specific antigen in serum by immunoradiometric assay. Clin Chem 36: 53-58, 1990.
20. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwive E: Prostatic-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
21. Brawer MK, Schifman RB, Ahmann FR, Ahmann ME, and Coulis KM: The effect of digital rectal examination on serum levels of prostatic specific antigen. Arch Pathol Lab Med 112: 1110-1112, 1988.